Trade Shin-Etsu Chemical Co., Ltd. - 4063 CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 108.6 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.022094% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.022351% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | JPY | ||||||||
Margin | 20% | ||||||||
Stock exchange | Japan | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 19031.2 |
Open* | 19279.6 |
1-Year Change* | 1.18% |
Day's Range* | 19195.8 - 19294.5 |
52 wk Range | 14.19K-20.00K |
Average Volume (10 days) | 1.63M |
Average Volume (3 months) | 24.73M |
Market Cap | 7,722.03B |
P/E Ratio | 10.78 |
Shares Outstanding | 394.85M |
Revenue | 2,753.96B |
EPS | 1,769.44 |
Dividend (Yield %) | 2.49017 |
Beta | 1.37 |
Next Earnings Date | Apr 25, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Feb 1, 2023 | 19229.7 | -49.9 | -0.26% | 19279.6 | 19294.5 | 19174.8 |
Jan 31, 2023 | 19031.2 | -154.6 | -0.81% | 19185.8 | 19185.8 | 19026.2 |
Jan 30, 2023 | 19140.9 | 244.3 | 1.29% | 18896.6 | 19150.9 | 18835.7 |
Jan 27, 2023 | 18243.3 | -323.1 | -1.74% | 18566.4 | 18707.0 | 18077.7 |
Jan 26, 2023 | 17534.1 | -16.0 | -0.09% | 17550.1 | 17550.1 | 17404.5 |
Jan 25, 2023 | 17425.4 | 129.7 | 0.75% | 17295.7 | 17470.3 | 17210.9 |
Jan 24, 2023 | 17330.4 | -115.8 | -0.66% | 17446.2 | 17470.2 | 17299.7 |
Jan 23, 2023 | 17100.3 | 96.8 | 0.57% | 17003.5 | 17147.1 | 16982.5 |
Jan 20, 2023 | 16756.1 | 57.8 | 0.35% | 16698.3 | 16772.1 | 16653.4 |
Jan 19, 2023 | 16782.1 | 99.8 | 0.60% | 16682.3 | 16788.1 | 16672.3 |
Jan 18, 2023 | 16896.8 | 284.3 | 1.71% | 16612.5 | 16925.7 | 16612.5 |
Jan 17, 2023 | 16572.6 | 268.3 | 1.65% | 16304.3 | 16646.4 | 16289.3 |
Jan 16, 2023 | 16307.3 | -70.8 | -0.43% | 16378.1 | 16419.0 | 16219.5 |
Jan 13, 2023 | 16577.6 | -49.9 | -0.30% | 16627.5 | 16747.2 | 16486.8 |
Jan 12, 2023 | 16662.4 | 90.0 | 0.54% | 16572.4 | 16731.2 | 16561.6 |
Jan 11, 2023 | 16571.6 | -65.9 | -0.40% | 16637.5 | 16647.4 | 16541.7 |
Jan 10, 2023 | 16587.6 | 24.0 | 0.14% | 16563.6 | 16608.5 | 16492.8 |
Jan 6, 2023 | 16033.0 | 253.3 | 1.61% | 15779.7 | 16109.8 | 15769.6 |
Jan 5, 2023 | 15959.2 | -60.9 | -0.38% | 16020.1 | 16049.0 | 15919.3 |
Jan 4, 2023 | 15794.7 | -94.7 | -0.60% | 15889.4 | 15930.3 | 15763.7 |
Shin-Etsu Chemical Co., Ltd. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|
Total revenue | 1237400 | 1441430 | 1594040 | 1543520 | 1496910 | 2074430 |
Revenue | 1237400 | 1441430 | 1594040 | 1543520 | 1496910 | 2074430 |
Cost of Revenue, Total | 868404 | 963008 | 1039980 | 987782 | 953203 | 1206420 |
Gross Profit | 369001 | 478424 | 554057 | 555743 | 543703 | 868003 |
Total Operating Expense | 999762 | 1107850 | 1194510 | 1137480 | 1109600 | 1400920 |
Selling/General/Admin. Expenses, Total | 113332 | 125739 | 132275 | 147531 | 148824 | 188666 |
Research & Development | 15009 | 13600 | 15536 | |||
Depreciation / Amortization | 2042 | 2262 | 2541 | 2171 | 2665 | 3014 |
Unusual Expense (Income) | 974 | 3239 | 4176 | 4909 | 2814 | |
Other Operating Expenses, Total | 1 | 1 | 1 | 1 | ||
Operating Income | 237643 | 333583 | 399529 | 406041 | 387304 | 673508 |
Interest Income (Expense), Net Non-Operating | 5878 | 7940 | 18912 | 23867 | 17069 | 21405 |
Other, Net | -1388 | -1215 | -3130 | -3891 | -2228 | -479 |
Net Income Before Taxes | 242133 | 340308 | 415311 | 426017 | 402145 | 696137 |
Net Income After Taxes | 178310 | 270059 | 313986 | 318291 | 299177 | 525032 |
Minority Interest | -2397 | -3822 | -4860 | -4263 | -5444 | -24914 |
Net Income Before Extra. Items | 175913 | 266237 | 309126 | 314028 | 293733 | 500118 |
Net Income | 175913 | 266237 | 309126 | 314028 | 293733 | 500118 |
Total Adjustments to Net Income | -1 | -2 | -1 | -1 | -1 | -1 |
Income Available to Common Excl. Extra. Items | 175912 | 266235 | 309125 | 314027 | 293732 | 500117 |
Income Available to Common Incl. Extra. Items | 175912 | 266235 | 309125 | 314027 | 293732 | 500117 |
Dilution Adjustment | -3 | -11 | -5 | -4 | -11 | -27 |
Diluted Net Income | 175909 | 266224 | 309120 | 314023 | 293721 | 500090 |
Diluted Weighted Average Shares | 426.107 | 426.572 | 425.831 | 415.916 | 415.883 | 415.789 |
Diluted EPS Excluding Extraordinary Items | 412.828 | 624.101 | 725.922 | 755.015 | 706.259 | 1202.75 |
Dividends per Share - Common Stock Primary Issue | 120 | 140 | 200 | 220 | 250 | 400 |
Diluted Normalized EPS | 414.512 | 630.127 | 733.336 | 755.015 | 715.04 | 1204.76 |
Gain (Loss) on Sale of Assets | 1703 |
Q4 2021 | Q1 2021 | Q2 2021 | Q3 2021 | Q4 2022 | |
---|---|---|---|---|---|
Total revenue | 406499 | 434239 | 507102 | 542362 | 590725 |
Revenue | 406499 | 434239 | 507102 | 542362 | 590725 |
Cost of Revenue, Total | 258358 | 264383 | 290332 | 312059 | 339651 |
Gross Profit | 148141 | 169856 | 216770 | 230303 | 251074 |
Total Operating Expense | 302262 | 305959 | 337783 | 360813 | 396365 |
Selling/General/Admin. Expenses, Total | 40950 | 41037 | 47185 | 48594 | 54864 |
Unusual Expense (Income) | 2955 | 538 | 266 | 160 | 1850 |
Other Operating Expenses, Total | -1 | 1 | 0 | 0 | 0 |
Operating Income | 104237 | 128280 | 169319 | 181549 | 194360 |
Interest Income (Expense), Net Non-Operating | 10528 | 2153 | 1893 | 1595 | 16244 |
Other, Net | -5663 | 398 | 1479 | 3638 | -6474 |
Net Income Before Taxes | 109102 | 130831 | 172691 | 186782 | 205833 |
Net Income After Taxes | 82507 | 98824 | 130011 | 140069 | 156128 |
Minority Interest | -2095 | -3097 | -4834 | -7837 | -9146 |
Net Income Before Extra. Items | 80412 | 95727 | 125177 | 132232 | 146982 |
Net Income | 80412 | 95727 | 125177 | 132232 | 146982 |
Total Adjustments to Net Income | -1 | -2 | 2 | -1 | 0 |
Income Available to Common Excl. Extra. Items | 80411 | 95725 | 125179 | 132231 | 146982 |
Income Available to Common Incl. Extra. Items | 80411 | 95725 | 125179 | 132231 | 146982 |
Dilution Adjustment | -3 | -8 | -1 | -27 | 9 |
Diluted Net Income | 80408 | 95717 | 125178 | 132204 | 146991 |
Diluted Weighted Average Shares | 415.979 | 415.933 | 415.759 | 415.744 | 415.72 |
Diluted EPS Excluding Extraordinary Items | 193.298 | 230.126 | 301.083 | 317.994 | 353.582 |
Dividends per Share - Common Stock Primary Issue | 140 | 0 | 150 | 0 | 250 |
Diluted Normalized EPS | 198.67 | 231.56 | 301.565 | 318.282 | 353.85 |
Gain (Loss) on Sale of Assets | 1703 |
- Annual
- Quarterly
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|
Total Current Assets | 1549610 | 1702920 | 1750470 | 1824520 | 1914910 | 2437980 |
Cash and Short Term Investments | 939266 | 1051840 | 1042120 | 1087820 | 1152920 | 1436080 |
Cash & Equivalents | 752675 | 854506 | 826680 | 836448 | 866882 | 1112780 |
Short Term Investments | 186591 | 197339 | 215444 | 251377 | 286039 | 323305 |
Total Receivables, Net | 273304 | 320679 | 331322 | 318303 | 337868 | 467695 |
Accounts Receivable - Trade, Net | 273304 | 320679 | 331322 | 318303 | 337868 | 467695 |
Total Inventory | 267156 | 282076 | 329492 | 365665 | 365031 | 453659 |
Other Current Assets, Total | 69881 | 48316 | 47531 | 52726 | 59089 | 80541 |
Total Assets | 2655640 | 2903140 | 3038720 | 3230480 | 3380620 | 4053410 |
Property/Plant/Equipment, Total - Net | 846570 | 899728 | 987960 | 1119920 | 1165150 | 1290160 |
Intangibles, Net | 10229 | 9405 | 8740 | 10099 | 8922 | 10535 |
Long Term Investments | 139441 | 145455 | 145409 | 129784 | 154324 | 165099 |
Other Long Term Assets, Total | 109789 | 145633 | 146139 | 146168 | 137311 | 149638 |
Total Current Liabilities | 317000 | 378421 | 391854 | 377794 | 363246 | 477759 |
Accounts Payable | 123823 | 136834 | 141027 | 136442 | 125410 | 177682 |
Accrued Expenses | 65121 | 72626 | 78599 | 77681 | 73596 | 73943 |
Notes Payable/Short Term Debt | 6976 | 0 | 6273 | 7490 | 8234 | 7509 |
Current Port. of LT Debt/Capital Leases | 5922 | 7094 | 735 | 1963 | 4746 | 7537 |
Other Current Liabilities, Total | 115158 | 161867 | 165220 | 154218 | 151260 | 211088 |
Total Liabilities | 522650 | 551370 | 571975 | 576271 | 565463 | 724114 |
Total Long Term Debt | 1742 | 8430 | 7624 | 20928 | 21474 | 23909 |
Long Term Debt | 1578 | 8430 | 7624 | 15124 | 15986 | 16940 |
Capital Lease Obligations | 164 | 5804 | 5488 | 6969 | ||
Deferred Income Tax | 98228 | 61476 | 62669 | 59378 | 55289 | 66833 |
Minority Interest | 57096 | 61258 | 65814 | 68927 | 71473 | 99910 |
Other Liabilities, Total | 48584 | 41785 | 44014 | 49244 | 53981 | 55703 |
Total Equity | 2132990 | 2351770 | 2466740 | 2654210 | 2815150 | 3329300 |
Common Stock | 119419 | 119419 | 119419 | 119419 | 119419 | 119419 |
Additional Paid-In Capital | 129626 | 129937 | 128299 | 128323 | 128954 | 129090 |
Retained Earnings (Accumulated Deficit) | 1858010 | 2071300 | 2284900 | 2415670 | 2618100 | 2995760 |
Treasury Stock - Common | -31213 | -30207 | -94702 | -7123 | -12612 | -15702 |
Unrealized Gain (Loss) | 22887 | 26446 | 22955 | 10296 | 25027 | 26841 |
Other Equity, Total | 34258 | 34869 | 5868 | -12374 | -63731 | 73891 |
Total Liabilities & Shareholders’ Equity | 2655640 | 2903140 | 3038720 | 3230480 | 3380620 | 4053410 |
Total Common Shares Outstanding | 426.383 | 426.57 | 416.805 | 415.857 | 415.547 | 415.445 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 1914910 | 1976540 | 2133340 | 2200440 | 2437980 |
Cash and Short Term Investments | 1152920 | 1159910 | 1281150 | 1266020 | 1436080 |
Cash & Equivalents | 866882 | 897692 | 954937 | 977241 | 1112780 |
Short Term Investments | 286039 | 262219 | 326216 | 288783 | 323305 |
Total Receivables, Net | 337868 | 366455 | 416595 | 457100 | 467695 |
Accounts Receivable - Trade, Net | 337868 | 366455 | 416595 | 457100 | 467695 |
Total Inventory | 365031 | 373492 | 387247 | 401114 | 453659 |
Other Current Assets, Total | 59089 | 76684 | 48350 | 76199 | 80541 |
Total Assets | 3380620 | 3499400 | 3676890 | 3759140 | 4053410 |
Property/Plant/Equipment, Total - Net | 1165150 | 1228150 | 1238730 | 1253840 | 1290160 |
Intangibles, Net | 8922 | 9347 | 10727 | 10569 | 10535 |
Long Term Investments | 150573 | 161338 | |||
Other Long Term Assets, Total | 141062 | 285359 | 294086 | 294292 | 153399 |
Total Current Liabilities | 363246 | 350176 | 392259 | 381942 | 477759 |
Accounts Payable | 125410 | 130851 | 143293 | 149691 | 177682 |
Accrued Expenses | 73596 | 3425 | 73943 | ||
Notes Payable/Short Term Debt | 8233 | 0 | 0 | 0 | 7508 |
Current Port. of LT Debt/Capital Leases | 4747 | 11669 | 8902 | 8530 | 7538 |
Other Current Liabilities, Total | 151260 | 204231 | 240064 | 223721 | 211088 |
Total Liabilities | 565463 | 566947 | 617548 | 618678 | 724114 |
Total Long Term Debt | 21474 | 17193 | 19445 | 19373 | 23909 |
Long Term Debt | 15986 | 17193 | 19445 | 19373 | 16940 |
Capital Lease Obligations | 5488 | 6969 | |||
Deferred Income Tax | 55289 | 66833 | |||
Minority Interest | 71473 | 77364 | 80958 | 88442 | 99910 |
Other Liabilities, Total | 53981 | 122214 | 124886 | 128921 | 55703 |
Total Equity | 2815150 | 2932460 | 3059340 | 3140460 | 3329300 |
Common Stock | 119419 | 119419 | 119419 | 119419 | 119419 |
Additional Paid-In Capital | 128954 | 129000 | 129087 | 129114 | 129090 |
Retained Earnings (Accumulated Deficit) | 2618100 | 2652910 | 2779030 | 2848790 | 2995760 |
Treasury Stock - Common | -12612 | -12270 | -16683 | -16251 | -15702 |
Unrealized Gain (Loss) | 25027 | 26521 | 29081 | 27811 | 26841 |
Other Equity, Total | -63731 | 16876 | 19404 | 31575 | 73891 |
Total Liabilities & Shareholders’ Equity | 3380620 | 3499400 | 3676890 | 3759140 | 4053410 |
Total Common Shares Outstanding | 415.547 | 415.578 | 415.368 | 415.402 | 415.445 |
- Annual
- Quarterly
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|
Net income/Starting Line | 242133 | 340308 | 415311 | 426017 | 402145 | 696137 |
Cash From Operating Activities | 295204 | 332800 | 401904 | 412383 | 401174 | 553592 |
Cash From Operating Activities | 93087 | 112016 | 137570 | 131172 | 143807 | 168788 |
Non-Cash Items | -5343 | -8508 | -21459 | -25635 | -20440 | -15762 |
Cash Taxes Paid | 62895 | 74791 | 121589 | 107824 | 101402 | 147448 |
Cash Interest Paid | 528 | 599 | 751 | 508 | 571 | 816 |
Changes in Working Capital | -34673 | -111016 | -129518 | -119171 | -124338 | -295571 |
Cash From Investing Activities | 1281 | -237602 | -181553 | -394547 | -250719 | -253723 |
Capital Expenditures | -136274 | -163718 | -228102 | -269428 | -237372 | -197556 |
Other Investing Cash Flow Items, Total | 137555 | -73884 | 46549 | -125119 | -13347 | -56167 |
Cash From Financing Activities | -37199 | -50006 | -164538 | -94055 | -91123 | -122504 |
Financing Cash Flow Items | 8495 | 825 | -507 | -6383 | 1321 | 761 |
Total Cash Dividends Paid | -48987 | -53301 | -74655 | -87410 | -91420 | -120481 |
Issuance (Retirement) of Stock, Net | 2960 | 1364 | -88902 | -9168 | -5507 | -3320 |
Issuance (Retirement) of Debt, Net | 333 | 1106 | -474 | 8906 | 4483 | 536 |
Foreign Exchange Effects | -13584 | 1952 | -7917 | -7001 | -2861 | 29963 |
Net Change in Cash | 245702 | 47144 | 47896 | -83220 | 56471 | 207328 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 402145 | 303522 | 696137 | ||
Cash From Operating Activities | 401174 | 266212 | 553592 | ||
Cash From Operating Activities | 143807 | 75649 | 168788 | ||
Non-Cash Items | -20440 | 68 | -15762 | ||
Cash Taxes Paid | 101402 | 66829 | 147448 | ||
Cash Interest Paid | 571 | 391 | 816 | ||
Changes in Working Capital | -124338 | -113027 | -295571 | ||
Cash From Investing Activities | -250719 | -164547 | -253723 | ||
Capital Expenditures | -237372 | -104001 | -197556 | ||
Other Investing Cash Flow Items, Total | -13347 | -60546 | -56167 | ||
Cash From Financing Activities | -91123 | -61985 | -122504 | ||
Financing Cash Flow Items | 1321 | 2743 | 761 | ||
Total Cash Dividends Paid | -91420 | -58176 | -120481 | ||
Issuance (Retirement) of Stock, Net | -5507 | -5938 | -3320 | ||
Issuance (Retirement) of Debt, Net | 4483 | -614 | 536 | ||
Foreign Exchange Effects | -2861 | 13495 | 29963 | ||
Net Change in Cash | 56471 | 53175 | 207328 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Nomura Asset Management Co., Ltd. | Investment Advisor | 5.0489 | 20439371 | -346472 | 2022-12-31 | LOW |
Capital Research Global Investors | Investment Advisor | 4.9571 | 20067611 | 2483311 | 2022-02-28 | LOW |
Mitsubishi UFJ Trust and Banking Corporation | Bank and Trust | 4.0807 | 16519634 | 16519634 | 2022-06-13 | LOW |
Nippon Life Insurance Company | Insurance Company | 3.7925 | 15353000 | -881330 | 2022-09-30 | LOW |
Sumitomo Mitsui Trust Asset Management Co., Ltd. | Investment Advisor | 3.4829 | 14099600 | -4912700 | 2022-09-15 | LOW |
Hachijuni Bank Ltd | Bank and Trust | 2.9124 | 11790000 | 0 | 2022-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.7435 | 11106269 | -99800 | 2022-12-31 | LOW |
Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 2.6595 | 10766200 | -237400 | 2022-09-15 | LOW |
Meiji Yasuda Life Insurance Company | Insurance Company | 2.6399 | 10687000 | 0 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.5018 | 10128000 | 872000 | 2022-09-30 | LOW |
Daiwa Asset Management Co., Ltd. | Investment Advisor | 2.3751 | 9614821 | 47561 | 2022-12-31 | LOW |
BlackRock Fund Advisors | Investment Advisor | 1.4122 | 5716773 | 5700073 | 2021-10-29 | LOW |
BlackRock Japan Co., Ltd. | Investment Advisor | 1.3958 | 5650600 | 3890200 | 2021-10-29 | LOW |
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | Investment Advisor | 1.3238 | 5359000 | 868896 | 2022-06-13 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2176 | 4929134 | -1244860 | 2021-10-29 | LOW |
MUFG Bank, Ltd. | Bank and Trust | 1.0516 | 4257309 | 4257309 | 2022-06-13 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.8815 | 3568710 | -111885 | 2022-12-31 | LOW |
Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 0.7601 | 3076937 | 72795 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5959 | 2412215 | -8700 | 2022-12-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 0.5784 | 2341535 | -16100 | 2022-12-31 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Shin-Etsu Chemical Co., Ltd. Company profile
About Shin-Etsu Chemical Co Ltd
Shin-Etsu Chemical Co., Ltd. is a Japan-based company primarily engaged in chemical business. The Company operates in six business segments. The Poly Vinyl Chloride and Chemicals segment manufactures and sells vinyl chloride, caustic soda products, chloromethane and methanol. The Silicone segment manufactures and sells Silicone products. The Functional Chemicals segment manufactures and sells cellulose derivatives, metal silicon, poval and synthetic sex pheromone. The Semiconductor Silicon segment manufactures and sells semiconductor silicon products. The Electronic and Functional Materials segment manufactures and sells rare earth magnet, packaging materials for Light Emitting Diode (LED), photoresists, mask blanks, synthetic quartz products, liquid fluoroelastomer and pellicle. The Process, Commercial and Technology Service segment provides resin processed products, exports technology and plant and others.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Shin-Etsu Chemical Co Ltd revenues increased 36% to Y1.484T. Net income applicable to common stockholders increased 66% to Y353.14B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from Y110.00 to Y150.00. Basic Earnings per Share excluding Extraordinary Items increased from Y513.25 to Y850.02.
Equity composition
FY'5-'07 1Q & 3Q's WAS & O/S are estimated. FY'04 1Q & 3Q:Non-detail. FY'07 Q2 DWAS, FY'07 Q3 WAS & o/s, FY'07 Q4 WAS were estimated. FY'08 Q1&Q3 O/S=WAS. FY'2011 Q1 DWAS was estimated.
Industry: | Diversified Chemicals |
丸の内永楽ビルディング20階
丸の内一丁目4番1号
CHIYODA-KU
TOKYO-TO 100-0005
JP
Income Statement
- Annual
- Quarterly
News

British Pound (GBP) Outlook: GBP/USD, EUR/GBP Ahead of BoE Rate Decision
Bank of England remains a dovish hiker. GBP at risk of another dovish twist
15:13, 1 February 2023
Central Bank Week: Fed, BOE, and ECB meeting previews - USD, EUR, GBP, S&P 500
A lookahead at possible Fed, BOE, and ECB meeting outcomes and market reactions.
14:40, 31 January 2023
FX Weekly Outlook: USD, GBP/USD, EUR/USD Analysis
USD, GBP/USD, EUR/USD forecasts for the week ahead.
16:33, 27 January 2023
WTI, Gold, Silver – commodities weekly forecast for the week ahead
Strength to strength in the commodity space, however, topside exhaustion begins to creep in
13:53, 27 January 2023
S&P 500, Nasdaq, DAX 40, Hang Seng technical update
Can the S&P 500 hold above its 2022 descending trend line?
12:44, 26 January 2023People also watch
Still looking for a broker you can trust?
Join the 480.000+ traders worldwide that chose to trade with Capital.com